While GLP-1 therapies such as Ozempic, Wegovy, Mounjaro and Zepbound are already well established in the Canadian market, the report notes that the 2026 pipeline reflects a focus on improved efficacy, more uses and longer dosing intervals [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php]
When it comes to beta-alanine consumption, the more the better for maximum gains
Cigna offers several plan types in Arizona including PPO, HMO, and marketplace plans some of which may include coverage for GLP-1 obesity medications when medically indicated
Cell-permeable 2-OG treatment partially phenocopied the effects of ML226, consistent with perturbed OGDHc and 2-OG accumulation stabilizing HIF-1 and decreasing 5hmC levels (Fig
The study was conducted from December 1, 2021 to June 30, 2022